Western India-based Commercial Production of Orthopaedic implants and instruments is looking to sellout.
Posted By - Corporate
Posted date - 17/04/2023
BUSINESS BRIEF
The Company has its Commercial Production of Orthopaedic implants and instruments. It is manufacturing the following major product segments:
- Trauma – Locking and Non-Locking Plates and Screws
- Intramedullary Nails
- Spine
- Maxillofacial
- Foot and Ankle
- Partial Prosthesis
Certifications:
- CDSCO manufacturing license
- CE Certification from European Notified Body
- ISO 13485: 2016
- ISO 9001: 2015
- WHO-GMP
- Free Sale Certification from CDSCO
- Free Sale Certification from Spain
Highlight: It is exporting its products to more than 30 countries in the world. More than 75% of its production is exported to these countries. It is expanding its international presence and continuously exhibits its products in International Exhibitions across the globe.
Manufacturing facility:
The Company’s manufacturing facilities are located in Western India. It has 1,68,000 Sq. Ft of Industrial Land with over 20,000 Sq. Ft. of Built-up area housing various manufacturing and processing facilities.
Proposal
Industry
Hospitals and Healthcare
Sub Industry
Surgical and Medical Devices
Deal Size
INR 13.5 - 15 Cr
Motives For Sellout
Retirement
Management is open to continue with the business for handholding the new investor/buyers
Business Operation Information
Industry
Hospitals and Healthcare
Sub-Industry
Surgical and Medical Devices
Division
Division`s Buyers/Customers
Division`s Products/Services
Division`s Products/Services
Division`s Products/Services
Division`s Products/Services
Division`s Products/Services
Division`s Products/Services
Financial Information |
2020 (in Cr) | 2021 (in Cr) | 2022 (in Cr) | 2023 (in Cr) |
|---|---|---|---|---|
Sales |
INR 6.7 Cr | INR 5.1 Cr | INR 6.3 Cr | INR 7 Cr |
EBITDA |
N.D | N.D | N.D | N.D |
PAT |
N.D | N.D | N.D | N.D |
TOTAL DEBT |
N.D | N.D | N.D | N.D |
Business Documents
Recommended Deals
India-based Healthcare - AI-assisted disease management platform is looking to s...
Sales (2023): INR 7 Cr
The company offers an AI assisted disease management platform that reduces cost ...